Pulmonology Book

http://www.fpnotebook.com/

IpratropiumAka: Ipratropium Bromide, Atrovent, Short-acting Anticholinergic Bronchodilator

Advertisement

  1. Indications
    1. Chronic Obstructive Pulmonary Disease (COPD)
    2. Asthma
  2. Mechanism
    1. Short-acting Anticholinergic Bronchodilator
  3. Dosing
    1. Atrovent MDI: 2-3 puffs three to four times daily
    2. Atrovent Nebulization: 1 ampule in nebulization solution every 6 hours prn
  4. Adverse Effects
    1. Serious adverse effects
      1. Anaphylaxis, Angioedema or other Hypersensitivity Reaction
      2. Paradoxical bronchospasm or Laryngospasm
      3. Exacerbation of Glaucoma
    2. Common adverse effects
      1. Cough
      2. Dry Mouth or oral irritation
      3. Gastrointestinal upset such as Nausea
      4. Urticaria or other rash
      5. Headache
      6. Nervous sensation

Ipratropium (C0027235)

Definition (MSH)A muscarinic antagonist structurally related to ATROPINE but often considered safer and more effective for inhalation use. It is used for various bronchial disorders, in rhinitis, and as an antiarrhythmic.
ConceptsOrganic Chemical (T109) , Pharmacologic Substance (T121)
MSHD009241
EnglishIpratropium, IPRATROPIUM PREPARATION, ISOPROPYLATROPINE N, N Isopropylatropine, N-Isopropylatropine
Spanishipratropio
Parent ConceptsAtropine Derivatives (C0004260), Anticholinergic bronchodilators (C0354764), [NT900] NASAL AND THROAT, TOPICAL, OTHER (C0973584), Muscarinic Antagonists (C0003385), Bronchodilator Agents (C0006280), Quaternary anticholinergic (C1289964), Duplicate concept (C1274013)
SourcesMSH, NDFRT, RXNORM, SCTSPA, SNOMEDCT, USPMG, VANDF
Derived from the NIH UMLS (Unified Medical Language System)


Atrovent (C0591130)

ConceptsOrganic Chemical (T109) , Pharmacologic Substance (T121)
MSHD009241
EnglishAtrovent
SourcesMSH, NCI, RXNORM
Derived from the NIH UMLS (Unified Medical Language System)



Navigation Tree